Lanreotide
Lanreotide is a synthetic analogue of somatostatin, a naturally occurring inhibitory hormone which blocks the release of several other hormones, including growth hormone, thyroid-stimulating hormone (TSH), insulin and glucagon. Lanreotide binds to the same receptors as somatostatin, with higher affinity to peripheral receptors, and has similar activity.
| Catalog Number | R1812 |
| Alternative Name(s) | Angiopeptin, Autogel, BIM-23014, BIM 23014, BIM23014, DC-13-116, Ipstyl, Somatuline, Lanreotidum, Lanreotida, Lanreotide, LS-153748, LS 153748, LS153748 |
| Research Area | Lanreotide (INN) is a medication used in the management of acromegaly and symptoms caused by neuroendocrine tumors, most notably carcinoid syndrome. It is a long-acting analogue of somatostatin, like octreotide. |
| Molecular Formula | C54H69N11O10S2 |
| CAS# | 108736-35-2, 127984-74-1 |
| Purity | >95% |
| Size | Inquiry |
| Supplier Page | https://www.creative-peptides.com/product/lanreotide-item-r1812-39404.html |